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Accepted 5 January 2016Thermoregulation is a vital function of the autonomic nervous system in response to cold and heat stress. Ther-
moregulatory physiology sustains health by keeping body core temperature within a degree or two of 37 °C,
which enables normal cellular function. Heat production and dissipation are dependent on a coordinated set of
autonomic responses. The clinical detection of thermoregulatory impairment provides important diagnostic
and localizing information in the evaluation of disorders that impair thermoregulatory pathways, including au-
tonomic neuropathies and ganglionopathies. Failure of neural thermoregulatory mechanisms or exposure to ex-
treme or sustained temperatures that overwhelm the body's thermoregulatory capacity can also result in
potentially life-threatening departures from normothermia. Hypothermia, deﬁned as a core temperature of
b35.0 °C, may present with shivering, respiratory depression, cardiac dysrhythmias, impaired mental function,
mydriasis, hypotension, and muscle dysfunction, which can progress to cardiac arrest or coma. Management in-
cludes warming measures, hydration, and cardiovascular support. Deaths from hypothermia are twice as fre-
quent as deaths from hyperthermia. Hyperthermia, deﬁned as a core temperature of N40.5 °C, may present
with sweating, ﬂushing, tachycardia, fatigue, lightheadedness, headache, and paresthesia, progressing to weak-
ness, muscle cramps, oliguria, nausea, agitation, hypotension, syncope, confusion, delirium, seizures, and coma.
Mental status changes and core temperature distinguish potentially fatal heat stroke from heat exhaustion.Man-
agement requires the immediate reduction of core temperature. Ice water immersion has been shown to be su-
perior to alternative cooling measures. Avoidance of thermal risk and early recognition of cold or heat stress are
the cornerstones of preventive therapy.
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Temperature is a critical variable in health and disease. Constraint of
human body core temperature within a degree or two of 37 °C, which is
the optimal temperature for normal cellular function, occurs in three
ways. The ﬁrst is stable climate, which maintains temperatures across
most of the surface of planet Earth within a range compatible with
human life. The second is the autonomic nervous system, which reacts
robustly to thermal challenges by orchestrating a complex array of neu-
ral responses below the level of conscious awareness. The autonomic re-
sponses to cold stress include cutaneous vasoconstriction to retain
bodily heat aswell asmetabolic and shivering thermogenesis. The auto-
nomic responses to heat stress include cutaneous vasodilatation, which
liberates heat by radiant and convective heat loss, and sweating, which
liberates heat by evaporation. The third and perhaps least predictable is
human behavior, which responds to thermal sensory input by seeking
warmth or coolness, but which also is responsible for getting people
into situations of cold or heat stress, some of which can threaten life
or health. Another aspect to human behavior is the healthcare
professional's response to thermoregulatory disorders, which draws
from knowledge of autonomic physiology to treat patients who have
been rescued from circumstances that challenge their capacity for
thermoregulation.
This clinical review has a dual emphasis. The ﬁrst is thermoregulato-
ry disorders, which are disorders of the autonomic nervous system that
impair the pathways involved in thermoregulation. Whereas these dis-
orders sometimes present with symptoms related to heat or cold stress,
more often the thermoregulatory deﬁcit is incidental to symptoms and
provides colocalizing information that is helpful to reaching an accurate
diagnosis. The second is illness related to heat stress or cold stress,
which encompasses common clinical presentations inwhich autonomic
thermoregulatory function or dysfunction plays a role. Environmental
conditions of extreme or prolonged heat or cold stress can overwhelm
human thermoregulatory capacity, even in healthy persons, but espe-
cially for those whose capacity is impaired. Each year in the United
States, for example, approximately 2000 people die from weather-
related causes of death (Berko et al., 2014). The National Center for
Health Statistics found that 63% of these were attributed to exposure
to excessive or prolonged natural cold, hypothermia, or both; whereas
31% were attributed to exposure to excessive natural heat, heat stroke,
or sun stroke. As these statistics were gathered from death certiﬁcates,
the numbers may underestimate the true incidence of fatal thermoreg-
ulatory catastrophe (Berko et al., 2014).
2. Measurement of body temperature
The bodily temperatures most relevant in medicine are those of the
internal organs, particularly the brain, heart and liver. The temperature
of the vital internal organs is referred to as the core temperature. The
clinical importance of the core temperature relates to the fact that the
central nervous system, especially the cerebellum, and the liver are es-
pecially sensitive to heat stress (Atha, 2013; Kiyatkin, 2010). Heat-
related injury also impacts the kidneys, gastrointestinal tract, andmyo-
cardium (Atha, 2013; Jardine, 2007; Wexler, 2002). A number of
methods are available in clinical practice, and each has its advantages
and disadvantages (Table 1).2.1. Invasive techniques
Whereas direct measurement of brain temperature in clinical settings
is impractical, the pulmonary artery temperature, as measured by a
thermistor in a pulmonary artery catheter, is considered the gold stan-
dard for accurate determination of core temperature in clinical settings
where invasive measurements are possible (Pearson et al., 2012; Lefrant
et al., 2003). Other internal sites at which core temperature has been
measured include the esophagus, intestines, rectum, and bladder
(Lefrant et al., 2003; Robinson et al., 1998). Monitoring of esophageal
temperature during left atrial radiofrequency procedures for atrial ﬁbril-
lation, for example, has been shown to reduce the risk of thermal injury
to the esophagus (Liu et al., 2012; Leite et al., 2011).
For the vast majority of patients who do not have indwelling cathe-
ters, rectal thermometry has evolved as the standard method for deter-
mining core temperature (Lefrant et al., 2003; Robinson et al., 1998).
Rectal thermometry is not ideal, however, as rectal temperatures may
lag changing temperatures in the blood and other deep organs
(Robinson et al., 1998; Eichna et al., 1951). Rectal thermometry also in-
volves physical and psychological discomfort, and there have been doc-
umented cases of nosocomial transmission of stool-borne pathogens
(Livornese et al., 1992;McAllister et al., 1986) and, very rarely, traumat-
ic injury to the rectum (Al-Qahanti et al., 2001).
2.2. Noninvasive techniques
In common clinical practice, noninvasivemethods approximate core
temperature indirectly. The traditional method of taking oral tempera-
turewith a sublingual mercury-in-glass thermometer has, in recent de-
cades, yielded to new technologies that avoid the potential hazards of
broken glass and liquid mercury (Zhen et al., 2014; Apa et al., 2013;
Batra and Goyal, 2013; El-Radhi and Patel, 2006; Gasim et al., 2013;
Jefferies et al., 2011; Penning et al., 2011). Themost sensitive tempera-
ture sensorsare thermistors,whichare semiconductors, theelectrical re-
sistance of which varies in proportion to temperature (Bhavaraju et al.,
2001). Other types of contact sensors include thermocouples, which
areconstructedwithapairofdissimilarmetalwires joinedatoneend, re-
sistance temperaturedetectors,whicharewirewindings orﬁlm serpen-
tines, and liquid crystal strips. These have in common a temperature-
dependent physical property that translates to a measurable change in
an electric circuit to which the sensor is connected (Jones, 2009). Tem-
perature can also be measured remotely by an infrared sensor pointed
at the skin or tympanicmembrane surface (Tse et al., 2015).
Numerous studies have compared the clinical use of rectal, oral, ax-
illary, tympanic membrane, and temporal artery thermometry, with
varying and at times conﬂicting results (Allegaert et al., 2014; Bodkin
et al., 2014; Charafeddine et al., 2014; Odinaka et al., 2014; Zhen et al.,
2014; Apa et al., 2013; Batra and Goyal, 2013; Gasim et al., 2013;
Huggins et al., 2012; Edelu et al., 2011; Penning et al., 2011; Jefferies
et al., 2011; El-Radhi and Patel, 2006; Craig et al., 2002; Greenes and
Fleisher, 2001). Considering these studies as awhole, it may be conclud-
ed that the appropriate choice of method depends on the clinical con-
text, as physiologic conditions vary considerably depending on
whether the patient is hyperthermic or hypothermic, the external envi-
ronment, the rate of thermal change, and the age and medical acuity of
the patient.
Table 1
Comparison of methods for measuring body temperature.
Site of
measurement
Advantages Disadvantages
Forehead
skin
Ease of use Highly inaccurate
Axillary Ease of use
Inexpensive
Approximates core
temperature in newborns
If normal, can rule out
hypothermia
Inaccurate in children and adults
due to air exposure and sweat
Oral Ease of use
Inexpensive
Hazards of broken glass and
mercury
Underestimates core
temperature due to air or
beverage exposure or variable
probe placement
Tympanic
membrane
Ease and speed of use
More closely estimates core
temperature than oral methods
Reasonably accurate in children
and adults
Accuracy is limited by air or
cerumen in ear canal
Temporal
artery
Ease of use in children
Accuracy as compared to other
noninvasive methods
Less accurate in children
younger than 5 and febrile
adults
Rectal Accurate core temperature at
steady state
Most reliable for assessing
exertional heat stroke
Uncomfortable
Lags changes in core
temperature
May underestimate hepatic or
brain hyperthermia
Potential for transmission of
stool-borne pathogens
Rarely traumatic injury to
rectum
Esophagus Reduced risk of thermal injury
to esophagus during left atrial
ablation procedures
Requires an invasive esophageal
probe
Bladder Useful indicator of core
temperature to prevent
intraoperative and
postoperative hypothermia
Requires insertion of a bladder
catheter
Lags changes in core
temperature during
cardiopulmonary bypass
Pulmonary
artery
Most accurate core
temperature
Requires an invasive pulmonary
artery catheter
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been shown to be inadequate formonitoring individuals exercising out-
doors in the heat (Bach et al., 2015; Casa et al., 2007a). Even rectal tem-
perature, however, does not always accurately reﬂect the temperature
in other deep organs, as in nonsteady state conditions rectal tempera-
tures lag changes in core temperature (Giesbrecht, 2000). In particular,
rectal temperature readings may underestimate hepatic temperature
and the potential for hepatocellular heat-related damage, as metabolic
activity in the liver contributes substantially to heat production
(Jardine, 2007). Oral temperature, although easier to access, does not
accurately reﬂect core temperature due to such factors as probe place-
ment, ingestion of hot or cold ﬂuids, and exposure to ambient air
(Mazerolle et al., 2011).
In the evaluation of hypothermia, measurement of rectal tempera-
ture is themost commonly usedmethod. Here also, rectal temperatures
lag changes in core temperature, which is more accurately assessed by
esophageal probes (Giesbrecht, 2000). Rectal thermometers used to as-
sess hypothermia should be capable of giving accurate readings at tem-
peratures below 34 °C (Cappaert et al., 2008). Although in cold
environments oral, tympanicmembrane, and axillary thermometers ex-
posed to air temperatures cannot diagnose hypothermia, they can rule it
out if the measured temperature is above 35 °C (Cappaert et al., 2008).
In the evaluation of children, less intrusivemethods have been stud-
ied extensively. Axillary thermometry compares favorably to rectal
measurement in newborns (Charafeddine et al., 2014) but is inaccurate
in children and adults (El-Radhi and Patel, 2006). Infrared tympanicthermometry provides reasonably accurate estimates of core tempera-
tures in children older than 5 years and adults and is useful in settings
where ease and speed of use are important (Gasim et al., 2013; Apa
et al., 2013; Edelu et al., 2011; Jefferies et al., 2011; Cabanac et al.,
1987). Infrared tympanic thermometry has limited accuracy, however,
as it measures the average temperature not only of the tympanic mem-
brane but also the air within the external auditory canal and heat radi-
ated from the inner canal wall. To reduce the inﬂuence of air on aural
temperature measurement, a cotton ball may be inserted into the
aural canal to insulate the probe from the environment (Giesbrecht,
2000). Additionally, cerumenmay occlude the sensor's view of the tym-
panic membrane, and some device manufacturers add a correction fac-
tor that may not be valid for all conditions (Jefferies et al., 2011; Edelu
et al., 2011; Craig et al., 2002). Insufﬁcient agreement of infrared tym-
panic thermometry with rectal thermometry across a series of compar-
ison studies has led some authors to recommend against its use in
situations where precise measurement of body temperature is needed
(Zhen et al., 2014; Huggins et al., 2012; Casa et al., 2007a; Craig et al.,
2002; Nierman, 1991).
Temporal artery thermometry has been shown in comparison stud-
ies to provide accuracy superior to that of other noninvasivemethods in
a variety of clinical settings (Reynolds et al., 2014; Allegaert et al., 2014;
Batra and Goyal, 2013; Greenes and Fleisher, 2001). Its diagnostic accu-
racy was lower in children younger than 5 years and in febrile adults
(Bodkin et al., 2014; Odinaka et al., 2014; Penning et al., 2011).
Whereas core temperature is a useful objective measurement to
deﬁne the boundaries of hazardous divergence from normothermia
and to monitor clinical changes, it is important to remember that tem-
perature is only a guide and not the endpoint of medical assessment.
More important is the physiologic state of the patient. In both hyper-
thermic and hypothermic patients the cardinal signal of illness is a
change in mental status (Santelli et al., 2014; Atha, 2013; Jardine,
2007; Giesbrecht, 2000).
3. Measurement of sweating
Anhidrosis, or the absence of sweating, is not easily assessed by the
patient's history alone unless it is extensive enough to cause heat intol-
erance or so markedly asymmetric that it is noticeable to the patient
(Cheshire and Kuntz, 2008). The patient who used to sweat profusely
during exposure to hot weather or when exercising vigorously but
whose skin now remains dry under those conditions may be suspected
to havewidespread anhidrosis (Cheshire and Kuntz, 2008; Cheshire and
Freeman, 2003).
At the bedside, loss of sweating is usually inapparent unless the pa-
tient is in a hot environment. Changes in baseline resting sweat activity
can be quite subtle. Asymmetric sweating loss, such as hemibody, re-
gional or distal anhidrosis, ismore easily discerned by palpating than vi-
sualizing the skin, as the texture of dry skin is less smooth (Cheshire and
Kuntz, 2008).
A number of laboratory tests are available for more sensitive and
precise clinical evaluation of sudomotor function (Illigens and
Gibbons, 2009). These rely on measuring a change in electrical conduc-
tance, a color change in an indicator dye, a sweat imprint on a soft me-
dium, or dynamic recording by a humidity sensor of sweat evoked by an
axon reﬂex in response to iontophoresis of a cholinergic agonist
(Table 2).
3.1. Sympathetic skin response
The sympathetic skin response consists of a momentary change of
the electrical potential of the skin, whichmay be spontaneous or reﬂex-
ively evoked by a variety of psychological stimuli (Vetrugno et al.,
2003). This response is most easily recorded in the palms and soles,
where sweating is controlled more by cortical than by hypothalamic
processes and hence does not play a signiﬁcant thermoregulatory role
Table 2
Comparison of methods of measuring sweating.
Method Advantages Disadvantages
Bedside
examination
Requires no special equipment Insensitive, particularly in
a cool environment
Sympathetic skin
response
Easily recorded with standard
nerve conduction equipment
Responses are highly
variable and attenuate
with repeated stimulation
Evaluates emotional more
than thermoregulatory
sweating
Thermoregulatory
sweating test
Evaluates central and peripheral
limbs of the thermoregulatory
response
Sensitive measure of the
anatomical distribution of
sweating and anhidrosis over
the anterior body surface
Evaluates the degree of
anhidrosis as an indicator of
susceptibility to heat stress
Useful in evaluating both
proximal and distal small ﬁber
neuropathies
Useful in diagnosing thoracic
radiculopathy
Useful in assessing anhidrosis
following surgical
sympathectomy
May not distinguish a
central from a peripheral
sudomotor deﬁcit
Messy, patient must
shower to remove
indicator dye
Time-consuming to
perform
Requires bulky, specialized
equipment and a dedicated
room
Anticholinergic
medications can confound
interpretation
Silastic imprint
test
Evaluates the number, volume,
and anatomic distribution of
droplets from individual sweat
glands
Equipment is fairly simple
Safe and well-tolerated
Time-consuming to
analyze results
Quantitative
sudomotor
axon reﬂex test
Speciﬁcally evaluates the
functional integrity of
postganglionic sudomotor
nerves
Sensitive and reproducible in the
evaluation of small ﬁber
neuropathy
Mildly uncomfortable
Anticholinergic
medications can confound
interpretation
Epidermal biopsy Sensitive and reproducible in the
evaluation of small ﬁber
neuropathy
Results are not confounded by
medications
Invasive, requires punch
biopsy of skin
Mild local infection occurs
rarely
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variability as well as limited sensitivity and speciﬁcity in the diagnosis
of autonomic neuropathies (Arunodaya and Taly, 1995; Gutrecht,
1994; Maselli et al., 1989; Niakan and Harati, 1988).
3.2. Thermoregulatory sweating test
Anatomic patterns of anhidrosis may be evaluated by the thermo-
regulatory sweating test (TST), which is a modiﬁcation of Guttmann's
quinizarin sweat test (Guttmann, 1947). The patient rests supine and
unclothed on a movable cart within an enclosed cabinet, inside of
which the temperature and humidity are carefully controlled, while
the patient's skin and oral temperatures are continuously monitored.
The heat is adjusted to induce a gradual rise in core temperature over
40 to 60 min to a target of 38.0 °C, which results in a maximal thermo-
regulatory sweating response (Fealey et al., 2008). Sweating over the
anterior body surface is visualized by applying an indicator powder,
such as corn starchmixed with alizarin red, which changes from yellow
to purple when wet (Fealey et al., 2008).
The TST has been shown to be a sensitivemeasure of the distribution
of thermoregulatory sweating over the anterior body surface (Fealey
et al., 1989; Low et al., 2006). The result indicates the surface area that
is recruited to sweat but not the volume of sweat produced (Fealey
et al., 2008). The area that lacks sweating may be expressedquantitatively as the percent anhidrosis (Fealey et al., 2008). The ana-
tomical pattern of anhidrosis can suggest speciﬁc categories of thermo-
regulatory disorders. For example, distal anhidrosis is typical of length-
dependent small ﬁber neuropathies (Cheshire and Low, 2007; Low
et al., 2006). Segmental or regional zones of anhidrosismay reﬂect local-
ized areas of sympathetic denervation as can be seen in thoracic
radiculopathy, cholinergic neuropathy, harlequin syndrome, Ross syn-
drome, autoimmune autonomic ganglionopathy, or multiple system at-
rophy (Cheshire and Low, 2007, 2008; Cheshire and Freeman, 2003;
Fealey et al., 1989). Extensive anhidrosis correlates with heat intoler-
ance (Mevorah et al., 1993).
As a normal TST requires both central and peripheral limbs of the
sweating response to be intact, the TST alone cannot distinguish be-
tween a central or peripheral sudomotor deﬁcit. When combined with
a test of peripheral sudomotor function, localizing power is greater
(Fealey et al., 2008; Cheshire and Low, 2007).
3.3. Silastic imprint test
The presence and volume of sweat droplets may be sampled in par-
ticular skin regions by the silastic imprint test. Silastic impressionmate-
rial is spread over a small area of the skin surface, which is then
stimulated iontophoretically with acetylcholine or pilocarpine. Once
the silastic has hardened, impressions left by sweat droplets from indi-
vidual eccrine glands are photographed and optically quantiﬁed to con-
struct sweat histograms (Stewart et al., 1994; Kennedy et al., 1984). A
limitation of this method has been the presence of artifacts from hair,
air bubbles, and variations in skin surface texture (Illigens and
Gibbons, 2009). Newer silicone materials have lessened some of these
artifacts (Vilches and Navarro, 2002).
A number of variations of this test have been developed. One is the
dynamic sweat test, which utilizes digital video photography of
pilocarpine-induced sweating through transparent tape powdered
with corn starch to enhance visual contrast (Provitera et al., 2010). An-
other is the quantitative direct and indirect test (QDIRT), which ana-
lyzes high-resolution digital photographs of silicone impressions of
sweat droplets (Gibbons et al., 2008).
3.4. Quantitative sudomotor reﬂex test
Anhidrosis caused by lesions at the level of the peripheral nervemay
be evaluated by the quantitative sudomotor axon reﬂex test (QSART),
which evaluates the postganglionic sudomotor axon (Low and Sletten,
2008). Acetylcholine electrophoresis is applied to the skin surface at
four standard limb sites: typically the forearm, proximal leg, distal leg,
and foot. The iontophoresed acetylcholine activates the sudomotor
axon terminal, generating an action potential, which then travels anti-
dromically along the sudomotor axon, and upon reaching a branch
point travels orthodromically to release endogenous acetylcholine
from a nerve terminal adjacent to the initially stimulated terminal.
The released acetylcholine traverses the neuroglandular junction and
binds to M3 muscarinic receptors on eccrine sweat glands to evoke a
sudomotor response. Sweat droplets are collected and evaporated in a
capsule secured to the skin surface and piped to a hygrometer, which
measures the sweat volume over time, which is typically 5 min of stim-
ulation followed by 5 min of additional recording (Low and Sletten,
2008; Low et al., 1983).
Under controlled conditions, which include a sufﬁciently warm skin
surface and the absence of anticholinergic medications, the QSART has
been shown to be sensitive and reproducible in healthy subjects (Low
et al., 1983) and in patients with axonal peripheral neuropathies (Low
et al., 1983, 1986). Sudomotor volumes are approximately three times
greater in men than in women and do not decrease with age (Low
et al., 1983). QSART has proved to be useful in diagnosing and monitor-
ing autonomic postganglionic involvement in peripheral neuropathies
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3.5. Epidermal biopsy
Structural assessment of sweat gland innervation is possible by eval-
uation of epidermal nerve ﬁber density. Distal leg skin biopsy with
quantiﬁcation of the linear density of intraepidermal nerve ﬁbers has
been shown to be a reliablemethod for the diagnosis of small ﬁber neu-
ropathy (Provitera et al., 2015; Joint Task Force of the EFNS and the PNS,
2010). Loss of sweat gland nerve ﬁber density correlates well with
anhidrosis by TST (Loavenbruck et al., 2014) and with worsening pe-
ripheral neuropathy (Lauria et al., 2015; Gibbons et al., 2010; Gibbons
and Freeman, 2009; Gibbons et al., 2009). With this technique mild lo-
calized skin infection has occurred at a frequency of 1.9: 1000 (Joint
Task Force of the EFNS and the PNS, 2010).
4. Thermoregulatory disorders
Disorders that impair thermoregulatory autonomic pathways may
increase the risk of heat-related or cold-related illness. However, they
do not always present in this way, as patientsmay retain sufﬁcient ther-
moregulatory capacity to tolerate and remain normothermic in their
particular environments. The clinical value of tests that detect even
asymptomatic degrees of thermoregulatory impairment lies in the diag-
nostic and localizing information they provide in the evaluation of a va-
riety of autonomic neurologic disorders.
4.1. Small ﬁber neuropathies
A prime example of a clinically important thermoregulatory deﬁcit
in a normothermic patient is small ﬁber neuropathy. Many peripheral
neuropathies selectively or disproportionately affect autonomic ﬁbers,
including those which innervate eccrine glands (Low and Sandroni,
2008). The aforementioned tests of sudomotor function are useful in
the diagnosis and assessment of severity of distal small ﬁber neuropa-
thies affecting sudomotor ﬁbers and are particularly sensitive in com-
parison in detecting early or selectively small ﬁber neuropathies
(Illigens and Gibbons, 2009; Cheshire and Low, 2007; Low et al.,
1986). Nerve conduction studies, which preferentially evaluate large
myelinated nerve ﬁbers, may be normal in patients with neuropathies
that selectively affect small caliber unmyelinated ﬁbers (Low and Hilz,
2008; Low et al., 2006).
In one series of 40 patients suspected of having distal small ﬁber
neuropathy on the basis of symptoms of distal burning, hyperalgesia,
and allodynia, QSART was abnormal in 80% of patients, TST was abnor-
mal in 72% of patients, and one or both tests were abnormal in 90% of
patients (Stewart et al., 1992). In another study of 125 patients with
symptoms of distal small ﬁber neuropathy related to a variety of causes,
but mostly idiopathic, QSART demonstrated length-dependent abnor-
malities in 74% of patients, TST showed distal anhidrosis in 59%, and
one or both tests showed distal abnormalities in 93% of patients (Low
et al., 2006). In patients with various types of distal small ﬁber neurop-
athy, the presence of QSART deﬁcits agreed well with skin biopsies
showing loss of epidermal C-ﬁbers (Singer et al., 2004; Novak et al.,
2001).
Diabetic neuropathy is the most prevalent peripheral neuropathy in
developed countries (Low and Hilz, 2008). In a large, longitudinal,
population-based study in Rochester, Minnesota, clinicalmanifestations
of peripheral neuropathywere present in approximately 50% of diabetic
patients, of which approximately 10% had a clinical autonomic neurop-
athy (Dyck et al., 1993;Dyck et al., 1992). Distal anhidrosiswas themost
common pattern, with the proximal extent of anhidrosis progressing
with the duration of neuropathy (Fealey et al., 1989).
The differential diagnosis of nondiabetic small ﬁber sensory and au-
tonomic neuropathies is extensive and encompasses acute and chronic,self-limited andprogressive phenotypes. Smallﬁber neuropathies range
from idiopathic, autoimmune, paraneoplastic, hereditary, toxic and
drug-related, to degenerative in etiology and have been reviewed in
detail elsewhere (Gibbons, 2014; Themistocleous et al., 2014;
Hoeijmakers et al., 2012; Low and Sandroni, 2008). Notably, Sjögren
syndrome commonly impairs sudomotor function and can cause gener-
alized anhidrosis (Fujita and Hatta, 2013; Pavlakis et al., 2012).
Autonomic ganglionic involvement should also be considered, par-
ticularly in acute or subacute presentations. Anhidrosis is among the
clinical features of autoimmune autonomic ganglionopathy, which is
characterized by antibodies against ganglionic α-3 acetylcholine recep-
tors and typically presents with orthostatic hypotension, gastrointesti-
nal dysmotility, bladder dysfunction, sicca symptoms, and impaired
pupillary responses (Winston and Vernino, 2010; Gibbons and
Freeman, 2009; Vernino et al., 2009).
4.2. Disorders of the response to cold
Many neurologic disorders can potentially impair the patient's re-
sponse to cold (Table 3). Any disorder that restricts mobility, such as
Parkinson's disease, stroke, spinal cord injury, or myopathy, may limit
the ability to generate heat by muscle contraction or may delay efforts
to reach shelter in cold weather (Meiman et al., 2015). Additionally,
neurologic disorders that impair the sensation of cold or cause inappro-
priate cutaneous vasodilatation, such as some peripheral neuropathies
andmyelopathies, may decrease thermoregulatory peripheral vasocon-
striction or the awareness of a cold environment (Petrone et al., 2014;
Brown et al., 2012; Tesfaye et al., 1994).
Additionally, some central nervous system disorders, such as
Wernicke's encephalopathy,may impair the generation of a thermoreg-
ulatory response in the hypothalamus (Reuter et al., 1985; Kearsley and
Musso, 1980). Hypothermia has been described in the context of hypo-
thalamic demyelination inmultiple sclerosis (Geny et al., 1992). The ep-
ileptic patient who is postictal following a generalized seizure may be
temporarily unable to withdraw from a cold environment. The risk of
hypothermia is greater in those with dementia or who have consumed
alcohol or sedative drugs that depress the sensorium (Daulatzai, 2010;
Turk, 2010). Additionally, drugs such as the opioid meperidine and the
α-adrenergic antagonist clonidine inhibit shivering (Cheshire, 2010).
Hypothermia does not typically occur in patients with hyperhidro-
sis, despite evaporative heat loss, unless the hyperhidrosis is unrelated
to heat stress (Cheshire and Fealey, 2008). A notable exception is epi-
sodic spontaneous hypothermia with hyperhidrosis associated with
agenesis of the corpus callosum (Shapiro et al., 1969). The latter feature
appears not to be the causative basis for the hypothermia, as hypother-
mia occurs only in a small proportion of individuals with agenesis of the
corpus callosum (Pazderska et al., 2013), and cases of Shapiro syndrome
without corpus callosum agenesis have been described (Rodrigues
Masruha et al., 2011; Dundar et al., 2008; Sheth et al., 1994). These pa-
tients do not shiver even during marked hypothermia (Sheth et al.,
1994). Positron emission tomography in Shapiro syndrome has shown
mild increases inmetabolism in the tectal plate, posterior pons andme-
dulla, and cerebellar vermis during hypothermic episodes (Pazderska
et al., 2013). Decreased cerebrospinal ﬂuid levels of homovanillic acid
and 5-hydroxyindoleacetic acid suggest that these patients may have
decreased activity in central dopaminergic and serotonergic pathways
(Rodrigues Masruha et al., 2011).
Additional risk factors for hypothermia include endocrine disorders
such as hypothyroidism, hypoglycemia, and adrenal insufﬁciency,
which impair metabolic thermogenesis (Petrone et al., 2014; Ulrich
and Rathlev, 2004).
4.3. Disorders of the response to heat
Numerous medical conditions can predispose to heat exhaustion or
nonexertional heat stroke (Table 3). These include autonomic disorders
Table 3
Factors that may increase susceptibility to thermal illness.
Condition Cold-related illness Heat-related illness
Environmental Exposure to extreme cold
Prolonged exposure to mild
cold
Cold water immersion or
submersion
Exposure to cold air, ice, or
snow
Lack of shelter or insulating
clothing
Malnutrition
Strenuous physical exercise in
hot weather
Summer heat waves
Urban environments that
retain heat
Sequestration in hot parked
automobiles
Personal protective equipment
that renders sweating
ineffective
General medical Hypoglycemia
Diabetic ketoacidosis
Hypothyroidism
Adrenal failure
Hypopituitarism
Renal failure
Shock
Sepsis
Anorexia nervosa
Thyrotoxicosis
Pheochromocytoma
Neurological Disorders that impair judgment
Dementia
Head trauma
Schizophrenia
Hepatic encephalopathy
Disorders that impair mobility
Recent trauma
Stroke
Spinal cord injury
Parkinson's disease
Multiple system atrophy
Myopathy
Severe peripheral neuropathy
Disorders that impair thermal
sensation
Peripheral neuropathy
Disorders that may impair
thermoregulatory responses
Wernicke encephalopathy
Stroke
Spinal cord injury
Guillain–Barré syndrome
Amyotrophic lateral sclerosis
Multiple sclerosis
Myopathy
Disorders that cause widespread
anhidrosis
Cholinergic neuropathy
Autoimmune autonomic
ganglionopathy
Chronic idiopathic anhidrosis
Botulism
Generalized small ﬁber
neuropathy
Sjögren syndrome
Multiple system atrophy
Fabry's disease
Bilateral cervical
sympathectomy
Disorders that increase
thermogenesis
Status epilepticus
Neuroleptic malignant
syndrome
Malignant hyperthermia
Pharmacological Alcohol
Sedatives
Phenothiazines
Opioids
Clonidine
Neuromuscular blocking
agents
General anesthetics
Carbonic anhydrase inhibitors
Anticholinergics
Antihistamines
Serotoninergics
Psychomotor stimulants
Diuretics
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liberate heat. Not all anhidrotic patients will experience heat-related ill-
ness, however, as anhidrosis may remain asymptomatic in the absence
of heat stress (Cheshire, 2010).
Widespread anhidrosis as the predominant clinical presentation is
often due to a cholinergic neuropathy, which may be accompanied by
other signs or symptoms of cholinergic failure such as sicca syndrome,
abnormal pupillary light responses, or intestinal pseudo-obstruction
(Cheshire and Freeman, 2003). When the onset is acute or subacute,
an autoimmune etiology should be considered. Antibodies to the gangli-
onic α-3 acetylcholine receptor are found in the sera of some patients
(Gibbons and Freeman, 2009; Kimpinski et al., 2009; Klein et al., 2003).
Other cases are due to acquired idiopathic generalized anhidrosis,
which is an immune-mediated disorder characterized by absence of
sweating, urticaria, elevated IgE levels, atrophy and degeneration of
the sweat glands, biopsies of which show inﬁltration by lymphocytes
and mast cells (Murakami et al., 1988). Skin biopsies in some patients
have shown occlusion of coiled ducts by an amorphous eosinophilicsubstance (Ogino et al., 2004). In other cases of anhidrosis the sweat
glands are morphologically normal, and microneurography shows in-
tact bursts of skin sympathetic activity consistent with deﬁcient cholin-
ergic transmission (Nakazato et al., 2004). Anhidrosis in some of these
patients responds to steroids (Nakazato et al., 2004).
Another cholinergic neuropathy is Ross syndrome, which is charac-
terized by the clinical triad of progressive segmental anhidrosis, Adie's
tonic pupils, and areﬂexia (Maceﬁeld, 2012; Xavier et al., 2009; Ross,
1958). The anhidrosis, whichmay be extensive enough to cause heat in-
tolerance, often occurs asymmetrically adjacent to areas of preserved or
compensatory sweating (Xavier et al., 2009; Weller et al., 1992). Phar-
macologic and histopathological studies have indicated a postganglionic
cholinergic neuronal deﬁcit (Perretti et al., 2003; Sommer et al., 2002;
Wolfe et al., 1995).
Chronic idiopathic anhidrosis is a syndrome characterized by heat
intolerance, in which patients become hot, ﬂushed, dizzy, dyspneic,
and weak in response to heat stress or exercise but do not sweat and
is distinguished from generalized autonomic failure by the absence of
orthostatic hypotension, somatic neuropathy, or other neurologic deﬁ-
cits (Lowet al., 1985). Chronic idiopathic anhidrosis has been associated
with hyperthermia and heat stroke (Freeman and Louis, 1994; Dann
and Berkman, 1992).
Various other autonomic neuropathies may also increase the poten-
tial for developing hyperthermia. Severe diabetic autonomic neuropa-
thy with widespread involvement of proximal sudomotor ﬁbers
occasionally causes heat intolerance (Low and Hilz, 2008; Cheshire
and Low, 2007; Dyck et al., 1993). In a TST study of 51 patients with di-
abetic neuropathy, global anhidrosis was present in 16% (Fealey et al.,
1989). Distal or generalized anhidrosis with heat intolerance may also
occur alongwith xerostomia and xerophthalmia as part of an autonomic
neuropathy in Sjögren syndrome (Goto et al., 2000; Wright et al., 1999;
Katayama et al., 1995). Generalized anhidrosis with heat intolerance
frequently occurs in Fabry's disease, which is an x-linked receive disor-
der of lipid metabolism in which deﬁciency of α-galactosidase A results
in the accumulation of ceramide trihexoside in vascular endothelial cells
(Germain, 2010; Kato et al., 1992; Kang et al., 1987). Patients who have
undergone bilateral surgical cervical sympathectomy may become in-
tolerant of heat, particularly if sudomotor innervation of the face is
obliterated (Santelli et al., 2014; Cheshire, 2010).
Further, widespread anhidrosis is characteristic of bothmultiple sys-
tem atrophy (Iodice et al., 2012; Kihara et al., 1991; Cohen et al., 1987)
and pure autonomic failure (Bannister et al., 1967; Fealey et al., 1985).
Spinal cord transection impairs thermoregulatory sweating below the
level of the lesion (Downey et al., 1976; Huckaba et al., 1976;
Seckendorf and Randall, 1961). Heat generation from the intense mus-
cle contractions of an epileptic seizure may contribute to hyperthermia
under existing conditions of external heat stress and may further com-
plicate status epilepticus (Betjemann and Lowenstein, 2015). Muscle ri-
gidity in Parkinson's disease, by contrast, does not cause hyperthermia
(Gillman, 2010).
Also at potential risk are patients taking drugs that inhibit sweating.
Carbonic anhydrase inhibitors, such as topiramate, zonisamide, and ac-
etazolamide, inhibit sweat production at the level of the secretory coil
clear cell or apex of ductal cells (de Carolis et al., 2003; Ben-Zeev et al.,
2003). There have been reports of carbonic anhydrase inhibitors causing
transient hypohidrosis with heat intolerance in children, who are ap-
proximately ten times more susceptible to the drugs' hypohidrotic ef-
fect than are adults (Incecik et al., 2012; Markowitz et al., 2010;
Knudsen et al., 2003; Ben-Zeev et al., 2003; de Carolis et al., 2003;
Arcas et al., 2001). Rarely, fatal heat stroke has been described in associ-
ation with topiramate therapy (Borron et al., 2013).
Other common examples of drugs that inhibit sweating include M3
anticholinergic agents, which include bladder antispasmodics, tricyclic
antidepressants, and neuroleptics (Lee et al., 2015; Gillman, 2010;
Cheshire and Fealey, 2008; Adubofour et al., 1996; Hermesh et al.,
2000; Clark and Lipton, 1984). These drugs block the binding of
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vents the inﬂux of extracellular calcium that triggers the efﬂux of potas-
sium and chloride ions responsible for isotonic ﬂuid egress from the
luminal side of the clear cell (Low et al., 1992). Intoxication with
drugs, such as salicylate and methylsalicylate, that uncouple oxidative
phosphorylation also can cause hyperthermia (Clark and Lipton, 1984).
Hyperthermia is one of the cardinal signs of serotonin syndrome, the
others being agitation, tremor,myoclonus,muscle rigidity, hyperreﬂexia,
and hyperhidrosis. This dose-related, potentially fatal syndrome occurs
in patients taking serotonin-selective reuptake inhibitors multiply or in
combinationwith other drugs, such asmeperidine, fentanyl, or tramadol,
that enhance the availability of serotonin in the brain (Paden et al.,
2013). The mechanism of hyperthermia and sweating is uncertain but
may involve a direct effect on hypothalamic 5-HT receptors (Marcy
and Britton, 2005).
Recreational abuse of psychomotor stimulants, such as cocaine, am-
phetamine, methamphetamine (METH), 3,4-methylenedioxy-metham-
phetamine (MDMA or “ecstasy”), or heroin, frequently cause
hyperthermia. In the United States, stimulant drugs resulted in 93,562
emergency room visits in 2009 (NINDA, 2011). Elevated body tempera-
ture is a nearly universal presenting sign in such cases (Matsumoto
et al., 2014). The mechanisms of hyperthermia have not been fully
elucidated but likely involve a combination of central and peripheral ef-
fects. Exposure to these drugs causes the release of dopamine, seroto-
nin, and norepinephrine in the central nervous system, with a direct
effect on brain areas involved in thermoregulation, such as the hypo-
thalamus, on which are located α1 and β adrenoreceptors. In support
of this hypothesis is the ﬁnding that propranolol prevents
methamphetamine-induced hyperthermia in laboratory mice (Albers
and Sonsalla, 1995). Evidence for a peripheral effect includes the obser-
vation thatmethamphetamine-induced hyperthermia in laboratory rats
is prevented by sympathectomy or adrenalectomy, which suggests that
stimulant release of norepinephrine from sympathetic nerve terminals
increases thermogenesis in skeletal muscles under the inﬂuence of glu-
cocorticoids (Makisumi et al., 1998). Contributingmechanisms to ensu-
ing hyperthermia may include activation of astrocytes and microglia,
peripheral catecholamine release, increased skeletal muscle metabo-
lism, tachycardia, hypertension, peripheral vasoconstriction, and cyto-
kine formation and release (Matsumoto et al., 2014; Kiyatkin, 2013;
Kiyatkin, 2005).
Additionally, psychomotor stimulants acutely raise brain metabolism
by increasing the release of monoamine neurotransmitters, which can
cause pathological brain hyperthermia (brain temperature N 40 °C) that
exceeds systemic hyperthermia (Matsumoto et al., 2014; Kiyatkin,
2013; Kiyatkin, 2005). When combined with potentially hyperthermic
environmental conditions such as heat and exercise, amphetamine-like
stimulants can induce heat stroke (Matsumoto et al., 2014; Kiyatkin,
2013; Kiyatkin, 2005). This tragic fact was highlighted by the death of
29-year-old British cyclist Tom Simpson while competing in the 1967
Tour de France. The outdoor temperature that day reached a sweltering
54 °C. Simpson collapsed during his approach of the summit of Ventoux,
and resuscitation efforts were unsuccessful. On his body were found two
empty tubes and a half-full one of amphetamine, the use of which at the
time was legal in professional cycling (Fotheringham, 2012).
Another cause of hyperthermia is neuroleptic malignant syndrome,
which is a potentially fatal, idiosyncratic condition that occurs in 0.2%
of patients taking dopamine 2 receptor antagonists, particularly halo-
peridol, aripiprazole, or ﬂupentixol (Su et al., 2014; Perry and Wilborn,
2012). Hyperthermia resulting from acute lithium intoxication has
also been described (Gill et al., 2003). Clinical signs consist of hyperther-
mia, rigidity, hyperhidrosis, tachycardia, labile blood pressure, tremor,
dysarthria, and delirium that progress over hours to days. Laboratory
ﬁndings typically include elevations in creatine kinase, liver enzymes,
and white blood count combined with low serum iron (Perry and
Wilborn, 2012; Rusyniak and Sprague, 2006). Although itsmajor feature
ofmuscle rigidity seems to suggest that the hyperthermia results from ahypermetabolic state, the degree of muscle contraction is insufﬁcient to
induce hyperthermia (Gillman, 2010). Central dopaminergic impair-
ment with defective heat dissipation has been proposed to explain the
hyperthermia (Di Rossa et al., 1988).
Malignant hyperthermia is an autosomal dominantly inherited dis-
order of skeletal muscle calcium regulation that in up to 70% of cases
is associated with mutations of the RYR1 gene encoding ryanodine re-
ceptor type 1 (Gomez, 2014; Larach et al., 2014; Rosenberg et al.,
2007; Rusyniak and Sprague, 2006). Approximately 1% result frommu-
tations of CACNA1S, which encodes a skeletal muscle calcium channel.
Upon exposure to volatile anesthetic agents, either alone or in combina-
tion with a depolarizing muscle relaxant, genetically predisposed indi-
viduals develop uncontrolled skeletal muscle hypermetabolism
causing hyperthermia, muscle rigidity, tachycardia, acidosis, and
hyperkalemia. Rhabdomyolysis with subsequent elevation in creatine
kinase may lead to renal failure (Larach et al., 2014; Rosenberg et al.,
2007).
5. Hypothermia
Acute exposure to cold causes peripheral vasoconstriction, shivering,
and increased metabolic heat production (Castellani et al., 2006), as
well as attenuation of thirst (Keneﬁck et al., 2004). Acute cold stress
also reduces plasma volume and increases urine ﬂow rate (Castellani
et al., 2006). The predominant mechanism of this so-called cold-
induced diuresis is redistribution of plasma volume from the periphery
to the central circulation in response to peripheral vasoconstriction
(Freund and Sawka, 1996; Vogelaere et al., 1992; Lennquist et al.,
1974). Cold-induced diuresis is attenuated in trained athletes (Yoshida
et al., 1999) and does not appear to be explained adequately by inhibi-
tion of release of arginine vasopressin (Freund and Sawka, 1996;
Hynynen et al., 1993).
Hypothermia is deﬁned as a core body temperature of b35.0 °C
(Petrone et al., 2014; Cheshire, 2010; Polderman, 2009; Cappaert
et al., 2008; Jurkovich, 2007; Ulrich and Rathlev, 2004; Giesbrecht,
2000). As heat loss occurs more rapidly than heat production in the
human body, any situation that promotes heat loss can hasten the
onset of hypothermia (Ulrich and Rathlev, 2004). Approximately 60%
of heat is lost through radiation, 10–15% through conduction and con-
vection, and 25–30% through evaporation and respiratory expiration
(Ulrich and Rathlev, 2004). In the United States, there are on average
more than 1300 deaths per year from hypothermia, which is approxi-
mately twice the number of deaths annually as for exposure to heat
(Meiman et al., 2015).
5.1. Causes of hypothermia
Hypothermia occurs following prolonged exposure to cold, wet, or
windy conditions once the body's ability to maintain a normothermic
core temperature is overwhelmed. Factors that can predispose to hypo-
thermia include winter sports activities, cold water immersion, or lack
of sufﬁcientlywarm clothing or shelter fromenvironmental coldweath-
er (Cappaert et al., 2008; Jurkovich, 2007). Neonates and the elderly are
at increased risk as they are less able to generate heat by shivering or
preserve heat by vasoconstriction. Children generate more metabolic
heat than adults, which is usually sufﬁcient to maintain body heat
while exercising but not during prolonged rest (Falk, 1998). The risk
of hypothermia is greater in those who are malnourished, alcoholic,
mentally ill, septic, in shock, or whose mobility is limited by disability
or recent injury, if they are less able to generate heat from muscle con-
traction or actively seek shelter (Brown et al., 2012; Brändström et al.,
2012; Jurkovich, 2007; Ulrich and Rathlev, 2004; Biem et al., 2003). Hy-
pothermia can occur even inwarm environments under conditions that
cause the body to lose more heat than it generates (Cappaert et al.,
2008).
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neuroprotectant effect following cardiac arrest, stroke, traumatic brain
or spinal cord injury. Therapeutic hypothermia has reached an accept-
able level of safety through the development of sophisticated cooling
systems using thermocouples and feedback sensors that allow for pre-
cise control of core temperature and is an area of active research in crit-
ical care medicine (Maznyczka and Gershlick, 2015; Sherman and
Wang, 2014; Macleod et al., 2010).
5.2. Diagnosis of hypothermia
Hypothermia classically is deﬁned as mild, moderate, or severe ac-
cording to core temperature but is best understood as a decrease in
body temperature that causes signs of physiologic dysfunction
(Table 4) (Cappaert et al., 2008; Ulrich and Rathlev, 2004; Durrer
et al., 2003). These categories derive from correlations of body temper-
aturemeasurements with clinical presentations of accidental hypother-
mia (Brown et al., 2012; Giesbrecht, 2000) and induced hypothermia in
the treatment of cardiac arrest, traumatic brain injury, and other medi-
cal conditions in the 1940s through the 1960s (Polderman, 2009). In
general, the physiologic state of the patient is more important to moni-
tor than the temperature (Giesbrecht, 2000).
Signs of mild hypothermia (core temperature 35°–32 °C) may in-
clude vigorous shivering, lethargy, apathy, impairment of ﬁne motor
skills, cold extremities, polyuria, pallor, tachypnea, and tachycardia.
With development of moderate hypothermia (core temperature 32°–
28 °C), physical signs may include depression of respirations and
pulse, slurred speech, further impairment of mental function, paradox-
ical undressing, gross impairment of motor control, cessation of shiver-
ing, cyanosis, muscle rigidity, mydriasis, atrial or ventricular cardiac
dysrhythmias, bradycardia, decreased blood pressure, hypoventilation,
hyporeﬂexia, and loss of consciousness. If severe hypothermia (core
temperature b 28 °C) develops, the patient may present with hypoten-
sion, pulmonary congestion and edema, muscle rigidity, areﬂexia,
oliguria, spontaneous ventricular ﬁbrillation, cardiac arrest, and comaTable 4
Clinical presentations of thermal illness.
Hypothermia
Severe (b28 °C) Moderate (28°–32 °C) Mild (32°–3
Mental status Delirium, hallucinations,
coma, may mimic death
Fatigue, agitation,
confusion, hallucinations,
lethargy, amnesia,
paradoxical undressing
Impaired jud
amnesia
Cutaneous Frostbite Cold, edematous Vasoconstric
followed by
hyperemia
Cardiovascular Bradycardia, spontaneous
atrial or ventricular
ﬁbrillation, hypotension,
asystole at b20 °C
J waves, atrial ﬁbrillation,
hypotension
Tachycardia
QT interval
prolongation
hypertensio
Respiratory Hypopnea, pulmonary
edema, apnea at b24 °C
Hypopnea, impaired cough
reﬂex
Tachypnea
Muscular Hypotonia, rhabdomyolysis Loss of shivering, rigidity Shivering
Neurologic Dilated nonreactive pupils
at b26 °C, stupor, areﬂexia
Sluggish pupillary
responses, hyporeﬂexia,
ataxia
Dysarthria, l
motor skills
Hepatic Decreased enzyme activity Decreased enzyme activity
Renal Oliguria Diuresis, renal tubular
acidosis
Diuresis from
decreased
hypothalam
of antidiuret
hormone
Hematologic Thrombocytopenia,
disseminated intravascular
coagulation, prolonged
prothrombin time
Decreased platelet function Hemoconce
Gastrointestinal Pancreatitis, gastric
erosions
Nausea, vomiting Ileus, gastric(Durrer et al., 2003). The skin is cold to the touch, the pupils are dilated,
and the pulse and respirations may be difﬁcult to detect. Severe cases
can mimic death. The clinical presentations of hypothermia, which are
quite variable among patients, are reviewed in greater detail elsewhere
(Brown et al., 2012; Brändström et al., 2012; Cheshire, 2010;
Polderman, 2009; Cappaert et al., 2008; Jurkovich, 2007; Castellani
et al., 2006; Ulrich and Rathlev, 2004; Giesbrecht, 2000; Fischbeck and
Simon, 1981).
When the core temperature cannot readily be measured, the Swiss
staging system distinguishes among ﬁve levels of hypothermia: HT I
with clear consciousness and shivering, HT II with impaired conscious-
ness without shivering, HT III with unconsciousness, HT IV with appar-
ent death, andHT Vwith death due to irreversible hypothermia (Brown
et al., 2012; Durrer et al., 2003).
Frostbite is a severe form of localized cold-induced tissue injury that
occurs when skin or deeper tissue temperature falls below −2 °C, at
which point ice crystals form at the cellular level, resulting in cellular
dysfunction or destruction and, during rewarming,microvascular occlu-
sion (Jurkovich, 2007). Severity ranges from hyperemia with edema to
blistering, hemorrhagic vesicles, tissue necrosis, and gangrene
(Cappaert et al., 2008; Jurkovich, 2007).
5.3. Management of hypothermia
Prevention of hypothermia during exposure to cold environments
includes wearing sufﬁciently warm clothing as well as education
about the risk factors and how to recognize the early signs of hypother-
mia. Clothing requirements in cold weather depend on metabolic rate,
ambient temperature, water exposure, and wind velocity (Castellani
et al., 2006). Heat loss can be minimized by wearing knit caps, bala-
clavas, headbands to cover the ears, and layering to adjust insulation
as physical activity increases (Castellani et al., 2006). Heightened sur-
veillance of exercisers is advised when wind-chill temperatures are
below −27 °C (Castellani et al., 2006). Cold weather athletes should
eat a well-balanced diet and replace ﬂuid lost through sweatingNormothermia Hyperthermia
5 °C) 37° ± 1 °C Heat exhaustion Heat stroke (N40.5 °C)
gment, Fatigue, thirst, irritability Delirium, confusion,
hallucinations, coma
tion Sweating, ﬂushed Flushed, loss of sweating in
classical, but not exertional,
heat stroke
, PR and
,
n
Tachycardia, postural
syncope
Heart failure, hypotension,
myocardial injury
Weakness, cramps
oss of ﬁne Headache, dizziness,
paresthesia
Seizures
Hepatic injury
ic release
ic
Oliguria Myoglobinuria, renal failure
ntration Thrombocytopenia,
disseminated intravascular
coagulation, prolonged
prothrombin time
erosions Nausea, vomiting Mucosal swelling, vomiting
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tive warming measures are necessary to prevent the heat loss that oth-
erwise would occur during general anesthesia, which temporarily
abolishes central thermoregulatory control, muscle contraction, and pe-
ripheral vasoconstriction (Horosz and Malec-Milewska, 2014).
Once hypothermia is recognized, prompt treatment is necessary to
avert preventable death. Wet or damp clothing should be removed
without delay, and the individual should be removed from wind or
rain to a warm, dry, sheltered environment. Mild hypothermia is best
managed with passive external warming using blankets or
metaloplastic sheets that reﬂect heat. The head should be covered. All
patients with hypothermia should be assumed to be dehydrated and re-
ceive supplemental ﬂuids (Cappaert et al., 2008; Jurkovich, 2007; Ulrich
and Rathlev, 2004; Delaney et al., 1989; Giesbrecht et al., 1987). Friction
massage should be avoided as this can exacerbate tissue damage from
frostbite (Cappaert et al., 2008).
Hypothermia is a condition of medical urgency. In addition to the
measures for treating mild hypothermia, vital signs should be closely
monitored. Any patient with suspected hypothermia who has signs of
cardiac dysrhythmia should bemoved gently to avoid precipitating par-
oxysmal ventricular ﬁbrillation, as the myocardium is more sensitive to
mechanical stimulation during deep hypothermia (Polderman, 2009;
Cappaert et al., 2008; Ulrich and Rathlev, 2004). Peripheral pulses in hy-
pothermic patients may be difﬁcult to palpate. In situations where the
EKG shows an organized cardiac electrical rhythm (other than ﬁbrilla-
tion), cardiopulmonary resuscitation with chest compression is contra-
indicated, despite the absence of a palpable pulse, because chest
compressionsmay convert an adequate perfusing rhythm to ventricular
ﬁbrillation (Jurkovich, 2007). The risk of ventricular ﬁbrillation in-
creases as core temperature in the severely hypothermic patient rises
above 28 °C. Below that temperature, cardiac dysrhythmias tend to be
refractory, for which reason resuscitative efforts should continue until
the absence of electrographic cardiac activity is documented after the
core temperature has risen to 28 °C–30 °C (Petrone et al., 2014).
Invasive active core warming methods may be indicated in patients
with severe hypothermia. These methods include heated intravenous
ﬂuids, inhalation rewarming, or peritoneal lavage (Danzi and Pozos,
1994). Rewarming by hemodialysis has also been used and has the
added beneﬁt of treating accompanying hyperkalemia and renal failure.
Themost efﬁcient (by an order of magnitude)method for rewarming is
cardiopulmonary bypass or extracorporeal active core rewarming
(CAVR), which is also themost invasive and is reserved for exceptional-
ly severe cases in appropriately equipped medical settings (Petrone
et al., 2014; Jurkovich, 2007; Giesbrecht, 2000). Antiarrhythmic drugs
may be required (Cappaert et al., 2008; Jurkovich, 2007; Ulrich and
Rathlev, 2004; Kornsberger et al., 1999; Walpoth et al., 1997; Daanen
and Van de Linde, 1992; Giesbrecht et al., 1987). Severe hypothermia
may exhibit afterdrop, which is a phenomenon in which heat-induced
vasodilation in the arms and legs during external active rewarming
with, for example, heating lamps sends a rush of relatively cold, acidic
blood from the periphery to the core with the potential to trigger cardi-
ac arrhythmias (Petrone et al., 2014; Ulrich and Rathlev, 2004). Active
core rewarming methods avoid this problem (Jurkovich, 2007).
6. Hyperthermia
Hyperthermia classically is deﬁned as a core body temperature of
N40.5 °C (McGeehin and Mirabelli, 2001; Clark and Lipton, 1984).
Some experts accept a deﬁnition of N40 °C (Atha, 2013; Jardine, 2007;
Wexler, 2002). Core temperature alone, however, is inadequate, and
the diagnosis of hyperthermia or heat stroke requires central nervous
system dysfunction (Santelli et al., 2014; Atha, 2013; Jardine, 2007).
The temperature threshold is somewhat arbitrary and has been based
on cumulative experience with patients evaluated for heat-related ill-
ness. Correlations betweenbody temperature and clinical consequences
of hyperthermia have been limited by the practical difﬁculty ofobtaining accurate core temperature measurements in the ﬁeld,
underrecognition of potentially unsafe elevations in core temperature,
individual differences in heat tolerance and susceptibility, and the spec-
trum of variations in heat stress presentations (Sawka et al., 2001; Clark
and Lipton, 1984). More important than measured temperature is the
clinical condition of the patient (Anderson et al., 1983).
Fever, which this review does not address speciﬁcally, is a subtype of
hyperthermia consisting of a regulated elevation in core temperature in
response to a pathological process, such as an infection, in which the
thermoregulatory system continues to function adequately. Unlike the
hyperpyrexia of fever, other forms of hyperthermia do not subside
when treated with cyclo-oxygenase inhibitors (Clark and Lipton, 1984).
In the United States more than 600 deaths occur annually from hy-
perthermia (Luber and Sanchez, 2006). During the years 1999–2003, a
total of 3442 U.S. deaths resulting from exposure to extreme heat
were reported, with an annual mean of 688 deaths. The cause of death
was recorded as exposure to excessive heat in 2239 (65%), and for the
remaining1203 (35%) hyperthermiawas recorded as a contributing fac-
tor (Luber and Sanchez, 2006). Some years have seenmuch higher rates
of heat stroke. In the United States, a severe heat wave in 1980 resulted
in 1700 deaths (Centers for Disease Control, 1981). In Europe, a severe
heat wave in August 2003 resulted in 14,800 heat-related deaths in
Lyon, France (Argaud et al., 2007).
These and other clusters of heat-related mortality during summer
heat waves have raised medical and public awareness of heat stroke,
which has improved recognition of vulnerable populations, such as
the elderly, which have decreased capacity to dissipate heat or in-
creased risk of dehydration (Santelli et al., 2014; Atha, 2013; Jardine,
2007). Prognostic factors contributing to heat-related deaths include
being conﬁned to bed (OR 6.44), not leaving home daily (OR 3.35),
being unable to care for oneself (OR 2.97), preexisting psychiatric dis-
ease (OR 3.61), cardiovascular disease (OR 2.48), and pulmonary dis-
ease (OR 1.61), whereas factors associated with more favorable
outcomes included functioning air conditioning (OR 0.23), visiting
cool environments (OR 0.34), increasing social contact (OR 0.40), taking
extra showers or baths (OR 0.32), and using fans (OR 0.60) (Bouchama
et al., 2007).
Brain cells and hepatic cells are exquisitely sensitive to hyperther-
mia. Irreversible neuronal damage begins at temperatures at or above
40 °C, which is only 3 °C above normal baseline, and progresses expo-
nentially with further increases in temperature (Kiyatkin, 2010). Cere-
bellar Purkinje cells are particularly vulnerable to heat injury
(Kiyatkin, 2010). Hyperthermia also increases blood–brain-barrier per-
meability, allowing entry of potentially neurotoxicmetabolites and sub-
stances that in conditions of health are retained in the periphery
(Kiyatkin, 2010). Hepatic and renal insult may occur also as a conse-
quence of secondary hypoperfusion as the sympathetic nervous system
shunts blood ﬂow to the skin to facilitate heat release (Atha, 2013).
Cytokine-mediated systemic inﬂammatory responses and disseminated
intravascular coagulation may lead to multiorgan failure and mortality
(Atha, 2013; Jardine, 2007).
Computed tomography (CT) of the brain in acute heat stroke is usu-
ally normal (Albukrek et al., 1997). Magnetic resonance imaging (MRI)
abnormalities are characteristically symmetric and include lesions hy-
perintense on FLAIR and DWI sequences in the cerebellum, external
capsule and adjacent lateral putamen, medial thalamus, and hippocam-
pus (Lee et al., 2009). Patchy cortical lesions may also be seen (Muccio
et al., 2013). Punctate hemorrhagic lesions have been described in the
cerebellar hemispheres, brain stem, corona radiata, and frontal lobes
on susceptibility-weighted images (Li et al., 2015a; Zhang and Li,
2014; Murcia-Gubianas et al., 2012). Diffusion tensor imaging has
shown fractional anisotropy of cerebellar white and gray matter (Li
et al., 2015b).
Postmortem studies of heat stroke have demonstrated severe loss of
cerebellar Purkinje cells and degeneration of Purkinje cell axons with
myelin pallor of the white matter of the cerebellar folia and of the
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typically vulnerable to hypoxia were spared (Bazille et al., 2005).
6.1. Causes of hyperthermia
Heat-related illness may be divided into passively and actively in-
duced mechanisms (Table 5). Classical heat stroke occurs in individuals
who have impaired thermoregulatory physiology and are deﬁcient in
the mechanisms for heat dissipation or lack the awareness or the
means to escape from a hot environment (Santelli et al., 2014; Clark
and Lipton, 1984; Anderson et al., 1983; Hart et al., 1982; Centers for
Disease Control, 1981). A paradoxical feature is that the skinmay appear
red, hot, and dry, as patients with classical heat stroke are often
anhidrotic (Clark and Lipton, 1984). The absence of sweating in a
heat-stressed individual should not be interpreted as evidence against
hyperthermia.
Exertional heat stroke, by contrast, typically occurs in healthy young
individuals who engage in strenuous physical exercise during hot
weather or in environments that restrict heat dissipation (Clark and
Lipton, 1984; Anderson et al., 1983). Sweating is an inadequate indica-
tor of thedegree of heat stress, but the cessation of sweating in exertion-
al heat stroke may be an ominous sign (Clark and Lipton, 1984). The
estimated 9000 high school athletes are treated for heat-related illness
each year in the U.S. (Kerr et al., 2013). Exertional heat stroke is, in
fact, one of the leading causes of preventable nontraumatic injury as
well as a recognized cause of sudden death during sport (Casa et al.,
2015; Casa et al., 2005). The risk is reduced but not eliminated by train-
ing (Sawka et al., 2001). At risk for exertional heat stroke are football
players, cyclists, and runners when strenuous exercise is performed in
very hot or humid conditions and evaporative cooling requirements ex-
ceed the environment's cooling capacity (Kerr et al., 2013; Sawka et al.,
2001). Also at risk are ﬁreﬁghters, ﬁeld laborers, toxicological clean-up
workers, astronauts, and military forces training or on active duty
when performing exertional activity while wearing protective clothing
that retains body heat (National Institute for Occupational Safety and
Health, NIOSH, 2013; Sawka et al., 2001).
During exercise the temperature of the brain is at least 0.2 °C higher
than that of the body (Nybo et al., 2002). An analysis of 1866 sudden
deaths in young American competitive athletes found that 46 (2%)
were caused by heat stroke (Maron et al., 2009). A study of active U.S.
military service members during 2010–2014 identiﬁed 344 incident
cases of heat stroke and 1683 cases of other heat injuries, which repre-
sented crude incidence rates of 0.25 and 1.22 per 1000 person-years, re-
spectively (AFHSC, 2015).
Every year, children left unattended in parked motor vehicles die
from heat stroke. Temperatures inside parked vehicles rise rapidly,Table 5
Clinical features of classical versus exertional heat stroke.
Classical Exertional
Circumstances Often in epidemics during
summer heat waves, occurs
without preceding physical
activity
Athletic activity or strenuous
exertion during variably warm
or hot weather or while
wearing heat-retaining
clothing
Age Children and elderly Adults young to middle age
Health Illness or medication
impairing thermoregulatory
sweating
Healthy
Sweating Often reduced or absent May be present
Acid base
disturbance
Respiratory alkalosis Lactic acidosis
Acute renal
failure
Rarely Frequently
Rhabdomyolysis Rarely Frequently
Disseminated
intravascular
coagulation
Rarely Frequentlyespecially during theﬁrst 15 to 30min. Onhot days temperatures inside
parked automobiles have been measured as high as 57 °C–78 °C, and
even in modest weather temperatures can reach 47 °C (McLaren et al.,
2005; Surpure, 1982). Highest temperatures occur in cars parked in di-
rect sunlight (Surpure, 1982). Cracking windows does not prevent this
rise (McLaren et al., 2005). In the U.S. from 1999 to 2007, the number
ofmotor vehicle-related child hyperthermia fatalitieswas 231. Their av-
erage core body temperature was 41.8 °C (Booth et al., 2010).
Urban living is also a risk factor for heat-related illness. Higher rates
of heat-related morbidity and mortality occur in city dwellers who re-
side on the top ﬂoors of apartment buildings or who do not have access
to air conditioning. The “urban heat island effect” refers to patterns of
city development, such as replacing trees with concrete surfaces, that
cause urban areas to retain heat throughout the evening in comparison
to suburban and rural areas (McGeehin and Mirabelli, 2001).
A simple tool for assessment of environmental heat safety is the wet
bulb globe temperature (WBGT) index, which was developed by the
U.S. military in the 1950s and is also used by civilian athletic groups to
calculate and stratify heat injury risk. The index is a weighted average
of measurements of heat (dry bulb temperature), humidity (wet bulb
temperature), and reﬂected heat (black globe temperature). WBGT
heat categorization has shown to be approximated by standard meteo-
rological data (Patel et al., 2013).
6.2. Diagnosis of hyperthermia
Illness related to heat stress classically has been divided into heat
cramps, heat exhaustion, and heat stroke (Anderson et al., 1983;
Malamud et al., 1946). Heat cramps are involuntary muscle spasms
that occur following exercise and respond to cooling, rest, and ﬂuid
and electrolyte replacement. Another minor form of heat stress is heat
edema, which occurs in elderly individuals and consists of swelling of
the feet and ankles in response to extreme heat. Miliaria, also known
as heat rash or prickly heat, is common in hot and humid climates and
presents with small, red, pruritic papules that result from plugging of
sweat gland ducts from dead skin or bacteria (Anderson et al., 1983;
Leithead, 1964).
Heat exhaustion is quite common and occurs along a continuum of
core temperatures. In a study of healthy, heat acclimated male soldiers
subjected to moderate to intense physical exercise in a hot climate,
50% of subjects incurred exhaustion from heat strain at core tempera-
tures ranging from 38.7 °C to 39.5 °C (Sawka et al., 2001). Heat exhaus-
tion is also related to high skin temperatures that are associated with
peripheral displacement of blood, which reduces venous return, cardiac
ﬁlling and stroke volume, resulting in cardiovascular strain (Sawka
et al., 2001; González-Alonso et al., 1985).
The transition from heat exhaustion to heat stroke is important to
recognizeandmayoccurquickly.Heat stroke (core temperatureN40.5 °-
°C) is the most serious degree of hyperthermia and if unrelieved is po-
tentially deadly (Berko et al., 2014; Anderson et al., 1983). The
presence or absence of sweating is an unreliable guide to diagnosing
or excluding heat stroke. To distinguish nonfatal heat exhaustion from
potentially fatal exertional heat stroke, and when monitoring the
acute treatment of heat stroke, measurement of core temperature
along with assessment of mental status are necessary (Atha, 2013;
Cheshire, 2010; Sucholeiki, 2005; D'Angelo, 2004; Wexler, 2002;
Bouchama and Knochel, 2002).
Hyperthermia may be classiﬁed in severity according to core tem-
perature and signs and symptoms (Table 4). Signs of heat exhaustion
(core temperature generally N38 °C) include sweating, ﬂushing, fatigue,
and tachycardia. Prolonged heat stress can lead to dehydration or pe-
ripheral displacement of blood volume with postural syncope (Santelli
et al., 2014; Atha, 2013). Heat exhaustion is characterized by profuse
sweating, ﬂushing, dizziness, headache, and paresthesia. Progressive
depletion of sodium and water reduce intravascular volume, which
may lead to weakness, muscle cramps, tachycardia, oliguria, nausea,
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Wexler, 2002). Heat exhaustion may be thought of as a protective
mechanism that inhibits further work during conditions of excessive
heat stress (Sawka et al., 2001).
As distinguished from heat exhaustion, heat stroke is often heralded
by central nervous system dysfunction including confusion, delirium,
hallucinations, seizures, or coma (Table 4). If epileptic seizures progress
to status epilepticus, thermogenesis from convulsive muscle contrac-
tion can further exacerbate hyperthermia (personal experience). Cere-
bral hypoperfusion or coagulopathy occasionally produces focal
neurological deﬁcits (Anderson et al., 1983). Common additional mani-
festations of heat stroke include hypotension, lactic acidosis, renal fail-
ure, gastrointestinal tract mucosal swelling, thrombocytopenia, and
disseminated intravascular coagulation. Irreversible injury to the
brain, myocardium, kidney, and liver may occur (Atha, 2013; Jardine,
2007; Wexler, 2002; Bouchama and Knochel, 2002; Anderson et al.,
1983).
The National Association of Medical Examiners Ad Hoc Committee
on the Deﬁnition of Heat-Related Fatalities deﬁnes heat-related death
as “a death in which exposure to high ambient temperature either
caused the death or signiﬁcantly contributed to it.” Speciﬁcally, they
recommend that the cause of death be certiﬁed as heat stroke or hyper-
thermia in cases where the measured antemortem temperature at the
time of collapsewas ≥40.6 °C, aswell as in caseswhere the core temper-
ature is lower, but cooling was attempted prior to arrival at the hospital
or there is a clinical history of heat-relatedmental status changes and el-
evated liver and muscle enzymes (Donoghue et al., 1997).
6.3. Management of hyperthermia
Heat exhaustion can usually be managed conservatively by remov-
ing the individual from the circumstances that led to heat-related symp-
toms. The individual should rest in a cool, shaded environment and
replace ﬂuid and electrolytes orally. Cooling may be facilitated by the
use of misting fans to moisten and blow a current of air across skin sur-
faces to promote evaporative heat loss. Refrigerated gel packs or ice
packsmay be applied to the forehead, neck, axillae, and groin. Excess in-
sulating clothing should be removed. Treatment should begin as soon as
symptoms occur in order to prevent progression to heat stroke
(Bergeron, 2014; Atha, 2013; Wexler, 2002).
Patients who do not improve with conservative measures or who
manifest mental status changes or cardiac dysrhythmias should receive
prompt attention in an emergency room or other acute care facility.
Treatment consists of administration of intravenous ﬂuid when dehy-
dration is suspected and correction of electrolyte imbalances involving
sodium, potassium, phosphate, calcium, or magnesium metabolism as
well as monitoring of core temperature (Santelli et al., 2014; Atha,
2013).
Hyperthermia is a medical emergency (Santelli et al., 2014). Prompt
recognition is paramount. The top priority for treatment is rapid reduc-
tion of core temperature. Prehospital care should begin immediately,
starting with dousing the patient with ice water, and then fanning to
promote evaporative heat loss and monitoring the airway and circula-
tion. Morbidity and mortality are greatly reduced if cooling measures
are applied within 30 min of recognition (Atha, 2013). Cooling to a
core temperature of approximately 38.5 °C within 30 min supports sur-
vival (Santelli et al., 2014; Clark and Lipton, 1984).
Ice water immersion remains the most effective intervention to
lower core temperature quickly and reducemorbidity and the risk of fa-
tality (Pryor et al., 2015; Newport and Grayson, 2012; Casa et al., 2007b;
Costrini, 1990). The theoretical concern that ice cold water immersion
might fail to cool down core temperature because of reﬂex peripheral
vasoconstriction or shivering has been strongly refuted by empirical ev-
idence of consistently superior cooling rates with cold water immersion
as compared to other modalities (Casa et al., 2007b). Cooling blankets
are ineffective (Atha, 2013).In situations where ice water immersion is not available, continual
dousing with ice water provides effective cooling (Casa et al., 2007b).
Treatment should commence as soon as possible. Unlike normothermic
individuals immersed in ice water, hyperthermic patients with exer-
tional heat stroke generally do not shiver, unless they are cooled too
long (Casa et al., 2007b). Shivering or muscle cramping, when they
occur, can be managed with intravenous diazepam or chlorpromazine
(Wexler, 2002; Eichner, 1998). Vigorous cooling efforts should be with-
drawn once the rectal or esophageal temperature reaches 38 °C–39 °C
(Stewart and Whitford, 2015; Atha, 2013). Use of a ﬂexible rectal
thermistor minimizes the potential for rectal trauma during cooling
(Casa et al., 2007b).
If signs of dehydration are present, intravenous ﬂuids should be ad-
ministered to restore circulatory volume andmaintain urine output. Not
all patients who present with exertional heat stroke are dehydrated
(Seraj et al., 1991), and as cardiac function may be impaired in heat
stroke, during rehydration the patient should be monitored for signs
of congestive heart failure (Santelli et al., 2014). Vasopressor therapy
may be required temporarily (Jardine, 2007). The management of heat
stroke requires close monitoring of cardiac and pulmonary function,
mental status, hematologic and coagulation parameters, electrolytes,
renal function, and hepatic enzymes to minimize organ damage
(Santelli et al., 2014; Atha, 2013; Jardine, 2007; Wexler, 2002).
Drug-induced hyperthermia usually may be treated more conserva-
tively unless heat exposure raises core temperature in excess of 40 °C.
The precipitating medication should be stopped (Clark and Lipton,
1984).
7. What more might be done?
During the last several decades, the textile and clothing industries
have developed protective clothing that insulates from cold weather
and breathes during hot weather more effectively and comfortably
than was possible for any previous generation in recorded history. Yet
the incidence of illness related to hypothermia and hyperthermia has
not signiﬁcantly declined.
More effective prevention will require greater public awareness of
the risk factors for heat-related and cold-related illness so that they
may be avoided or minimized. City planners might design urban land-
scapes differently to create more thermally tolerable environments,
which could confer additional esthetic beneﬁts (Stone et al., 2014).Min-
iaturized electronics may eventually lead to the development of safe,
comfortable, externally or internally placed smart devices to monitor
temperature and signal early warnings of impending hypothermia or
hyperthermia. Meanwhile, there is an ongoing need for preventive edu-
cation of athletes, outdoor adventurers, and the healthcare profes-
sionals who are called to treat their illnesses related to cold and heat
exposure.
8. Conclusion
Autonomic disorders frequently impair thermoregulatory systems,
testing of which is an important component of clinical diagnosis. Addi-
tionally, thermoregulatory failure or exposure to environmental condi-
tions that overwhelm the body's thermoregulatory capacity can present
with hypothermia or hyperthermia, both of which carry substantial risk
of morbidity and mortality. Prompt recognition and treatment are nec-
essary to preserve life and health.
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